Crowdonomics
All companies
BNNano, Inc. logo

BNNano, Inc.

Operating

Industrial & Manufacturing · Founded 2016

BNNano leverages cutting edge materials science innovation to transform, revitalize, revolutionize, and add value to industrial commodities.

Post-money valuation ⓘ
$23.9M
As of Feb 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$2,068,391
Crowd $1.3M · Private $787K · 7 rounds since 2017
Latest share price
$1.87
Reg CF · Common Stock · Sep 2022 offering price

Financials

FY2018–FY2024 · from SEC filings · hover any figure for its source
$51K
−$1.2M
2018
2019
$48K
−$2.2M
2020
$112K
−$957K
2021
$281K
−$717K
2022
$172K
−$200K
2023
$686K
$158K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 audited*
FY2019 audited*
FY2020 unaudited
FY2021 unaudited
FY2022 unaudited
FY2023 unaudited
FY2024 unaudited
Income statement
Revenue
$50,851
—
$48,283
$112,114
$280,505
$172,312
$685,555
Cost of goods sold
$5,122
—
$8,381
$34,968
$59,283
$13,596
$132,853
Gross margin
90%
—
83%
69%
79%
92%
81%
Net income
-$1,208,527
—
-$2,211,223
-$956,926
-$716,910
-$200,487
$157,782
Taxes paid
$25,185
—
$5,593
$5,790
$4,753
$5,359
$5,179
Balance sheet
Cash
$235,061
—
$196,438
$38,169
$38,169
$38,169
$69,333
Accounts receivable
$0
—
$0
$0
$0
$0
$0
Total assets
$355,732
—
$289,257
$536,694
$169,994
$107,326
$153,986
Short-term debt
$26,628
—
$44,231
$36,993
$106,932
$55,013
$5,692
Long-term debt
$1,270,000
—
$1,526,800
$1,465,000
$1,465,000
$1,548,750
$1,503,144
Total liabilities
$1,296,628
—
$1,571,031
$1,501,993
$1,571,932
$1,603,763
$1,508,836
Other
Headcount
—
6
—
6
6
6
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$20.0M
pre-money
$23.7M
pre-money
Reg CF · Common · Feb 2021
Reg CF · Common · Sep 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$1.87$0.935$1.70
Feb 2021Sep 2022
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Dec 31, 2021
ClassOutstandingVotes / shareShare of totalLast price
Common Stock12,395,447—100.0%$1.87Sep 2022

Shares outstanding over timein today's share terms

12M6.2M0
Dec 2019Dec 2021
Common StockRound opened

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $212.1K / $3MPost-money $23.9M
Raised $40KInvestors 3
Raised $60.2KInvestors 2
Raised $1.1M / $3MPost-money $21.1M
Raised $55.2KInvestors 2
Raised $390.4KInvestors 2
Raised $240.9KInvestors 16

Team

2 people
Jason Taylor
Board Member
Steve Wilcenski
Principal Executive Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 4 of 6 annual reports (FY2020–FY2025)

16 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-TRFeb 20, 20260001734214-26-000005
    EDGAR
  • Form C-ARFeb 17, 20260001734214-26-000003
    EDGAR
  • Form C-ARFeb 17, 20260001734214-26-000004
    EDGAR
  • Form C-ARFeb 6, 20260001734214-26-000002
    EDGAR
  • Form C-UAug 31, 20230001669191-23-000807
    EDGAR
  • Form C/ADec 22, 20220001669191-22-001179
    EDGAR
  • Form DNov 7, 20220001734214-22-000002
    EDGAR
  • Form C/AOct 19, 20220001669191-22-000991
    EDGAR
Source: ManualCIK 0001734214Share price $1.87

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.